Advertisement

Index by author

May 01, 2004; Volume 32,Issue 5

A

  1. Ang, Catharina Y. W.

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

B

  1. Bombail, Vincent

    1. ROLE OF Sp1, C/EBPα, HNF3, AND PXR IN THE BASAL- AND XENOBIOTIC-MEDIATED REGULATION OF THE CYP3A4 GENE
      Vincent Bombail, Kevin Taylor, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition May 2004, 32 (5) 525-535; DOI: https://doi.org/10.1124/dmd.32.5.525

  2. Bonner, Johanne

    1. PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566

  3. Bosron, William F.

    1. HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505

C

  1. Cai, Hongbo

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

  2. Christensen, Magnus

    1. THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484

  3. Conney, Allan H.

    1. STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE
      Mime Nagai, Allan H. Conney and Bao Ting Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 497-504; DOI: https://doi.org/10.1124/dmd.32.5.497

  4. Covey, Joseph M.

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

  5. Cui, Yan Yan

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

D

  1. Davis, Wilhelmina I.

    1. HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505

  2. Dickson, Janet

    1. PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566

  3. Duffel, Michael W.

    1. INFLUENCE OF PHENYLALANINES 77 AND 138 ON THE STEREOSPECIFICITY OF ARYL SULFOTRANSFERASE IV
      Jonathan J. Sheng, Atmaja Saxena and Michael W. Duffel
      Drug Metabolism and Disposition May 2004, 32 (5) 559-565; DOI: https://doi.org/10.1124/dmd.32.5.559

E

  1. Egorin, Merrill J.

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

  2. Eiseman, Julie L.

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

  3. Eliasson, Erik

    1. THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484

F

  1. Forrest, Gerald L.

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

  2. Fourcade, Julien

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

  3. Fredenburg, Tyler B.

    1. HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505

  4. Frye, Reginald

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

G

  1. Gibson, G. Gordon

    1. ROLE OF Sp1, C/EBPα, HNF3, AND PXR IN THE BASAL- AND XENOBIOTIC-MEDIATED REGULATION OF THE CYP3A4 GENE
      Vincent Bombail, Kevin Taylor, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition May 2004, 32 (5) 525-535; DOI: https://doi.org/10.1124/dmd.32.5.525

  2. Griffin, Sarah J.

    1. COMPARISON OF FRESH AND CRYOPRESERVED RAT HEPATOCYTE SUSPENSIONS FOR THE PREDICTION OF IN VITRO INTRINSIC CLEARANCE
      Sarah J. Griffin and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 552-558; DOI: https://doi.org/10.1124/dmd.32.5.552

  3. Gu, Helen

    1. PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566

H

  1. Hallifax, David

    1. QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTES
      Hannah M. Jones, David Hallifax and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 572-580; DOI: https://doi.org/10.1124/dmd.32.5.572

  2. Holleran, Julianne L.

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

  3. Houston, J. Brian

    1. COMPARISON OF FRESH AND CRYOPRESERVED RAT HEPATOCYTE SUSPENSIONS FOR THE PREDICTION OF IN VITRO INTRINSIC CLEARANCE
      Sarah J. Griffin and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 552-558; DOI: https://doi.org/10.1124/dmd.32.5.552
    2. QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTES
      Hannah M. Jones, David Hallifax and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 572-580; DOI: https://doi.org/10.1124/dmd.32.5.572

  4. Hutzler, J. Matthew

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

I

  1. Igarashi, Takashi

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

  2. Ishiguro, Naoki

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

J

  1. Johansson, Inger

    1. THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484

  2. Jones, Hannah M.

    1. QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTES
      Hannah M. Jones, David Hallifax and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 572-580; DOI: https://doi.org/10.1124/dmd.32.5.572

K

  1. Kishimoto, Wataru

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

  2. Klunk, Lewis J.

    1. AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545

  3. Kobayashi, Yasuna

    1. RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479

  4. Kohyama, Noriko

    1. RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479

  5. Komoroski, Bernard J.

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

L

  1. Lanusse, C.

    1. COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536

  2. Lehmann, Thomas

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

  3. Lifschitz, A.

    1. COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536

M

  1. Ma, Bennett

    1. CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473

  2. Mangold, James B.

    1. PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566

  3. Mitroka, James G.

    1. AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545

  4. Murry, Daryl J.

    1. HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505

  5. Musser, Steven M.

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

N

  1. Nagai, Mime

    1. STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE
      Mime Nagai, Allan H. Conney and Bao Ting Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 497-504; DOI: https://doi.org/10.1124/dmd.32.5.497

  2. Nozawa, Takashi

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

O

  1. Ohbayashi, Masayuki

    1. RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479

  2. Ohshiro, Naomi

    1. RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479

P

  1. Pan, Su-Shu

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

  2. Parise, Robert A.

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

  3. Pis, A.

    1. COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536

  4. Plant, Nick

    1. ROLE OF Sp1, C/EBPα, HNF3, AND PXR IN THE BASAL- AND XENOBIOTIC-MEDIATED REGULATION OF THE CYP3A4 GENE
      Vincent Bombail, Kevin Taylor, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition May 2004, 32 (5) 525-535; DOI: https://doi.org/10.1124/dmd.32.5.525

Q

  1. Quinney, Sara K.

    1. HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505

R

  1. Rane, Anders

    1. THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484

  2. Rodrigues, A. David

    1. CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473

  3. Rodriguez, Lolita C.

    1. PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566

  4. Roongta, Vikram A.

    1. AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545

  5. Rordorf, Christiane

    1. PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566

S

  1. Saito, Asami

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

  2. Sakai, Kenji

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

  3. Sallovitz, J.

    1. COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536

  4. Sandberg, Mia

    1. THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484

  5. Sanghani, Sonal P.

    1. HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505

  6. Saxena, Atmaja

    1. INFLUENCE OF PHENYLALANINES 77 AND 138 ON THE STEREOSPECIFICITY OF ARYL SULFOTRANSFERASE IV
      Jonathan J. Sheng, Atmaja Saxena and Michael W. Duffel
      Drug Metabolism and Disposition May 2004, 32 (5) 559-565; DOI: https://doi.org/10.1124/dmd.32.5.559

  7. Schrag, Michael L.

    1. CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473

  8. Sheng, Jonathan J.

    1. INFLUENCE OF PHENYLALANINES 77 AND 138 ON THE STEREOSPECIFICITY OF ARYL SULFOTRANSFERASE IV
      Jonathan J. Sheng, Atmaja Saxena and Michael W. Duffel
      Drug Metabolism and Disposition May 2004, 32 (5) 559-565; DOI: https://doi.org/10.1124/dmd.32.5.559

  9. Strom, Stephen C.

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

  10. Subramanian, Raju

    1. CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473

T

  1. Tamai, Ikumi

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

  2. Tang, Cuyue

    1. CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473

  3. Taylor, Kevin

    1. ROLE OF Sp1, C/EBPα, HNF3, AND PXR IN THE BASAL- AND XENOBIOTIC-MEDIATED REGULATION OF THE CYP3A4 GENE
      Vincent Bombail, Kevin Taylor, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition May 2004, 32 (5) 525-535; DOI: https://doi.org/10.1124/dmd.32.5.525

  4. Tracy, Timothy S.

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

  5. Tsuchiya, Ayumi

    1. RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479

  6. Tsujihata, Akiko

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

V

  1. Venkataramanan, Raman

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

  2. Virkel, G.

    1. COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536

W

  1. White, Kevin D.

    1. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

Y

  1. Yamamoto, Toshinori

    1. RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479

  2. Yokoyama, Kazutoshi

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

  3. Yotsumoto, Takafumi

    1. INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

Z

  1. Zhang, Donglu

    1. AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545

  2. Zhang, Shimin

    1. INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

  3. Zhao, Weiping

    1. AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545

  4. Zhu, Bao Ting

    1. STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE
      Mime Nagai, Allan H. Conney and Bao Ting Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 497-504; DOI: https://doi.org/10.1124/dmd.32.5.497

  5. Zhu, Mingshe

    1. AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545
Back to top

In this issue

Advertisement